Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Agent Drug-Coated Balloon Demonstrates Superiority to Uncoated Balloon Angioplasty in the AGENT IDE Trial
10/30/2023

Boston Scientific News

Boston Scientific News
The AGENT DCB is a paclitaxel-coated balloon catheter designed to re-open coronary vessels and then transfer the therapeutic drug to the vessel wall to help prevent in-stent restenosis reoccurrence.
The AGENT DCB is a paclitaxel-coated balloon catheter designed to re-open coronary vessels and then transfer the therapeutic drug to the vessel wall to help prevent in-stent restenosis reoccurrence.
The AGENT DCB is a...
10/30/2023
Cath Lab Digest
News
TRISCEND II Six-Month Data for First 150 Patients Successfully Demonstrate Safety and Efficacy of Edwards Evoque System for Severe Tricuspid Regurgitation
10/26/2023

Edwards Lifesciences News

Edwards Lifesciences News
The outcomes for the first 150 patients of the TRISCEND II trial achieved the primary safety endpoint at 30 days and both co-primary effectiveness endpoints at six months, demonstrating superiority to OMT alone.
The outcomes for the first 150 patients of the TRISCEND II trial achieved the primary safety endpoint at 30 days and both co-primary effectiveness endpoints at six months, demonstrating superiority to OMT alone.
The outcomes for the first 150...
10/26/2023
Cath Lab Digest
Philippe Généreux, MD
aortic stenosis
Novel Research on Aortic Stenosis From egnite, Inc.’s Database Presented at Transcatheter Cardiovascular Therapeutics Conference 2023
10/25/2023
“This research is the first of its kind to look at such a large cohort of AS patients over a four-year span. Findings serve as a stark reminder of the poor prognosis associated with untreated AS irrespective of severity, suggesting patients...
“This research is the first of its kind to look at such a large cohort of AS patients over a four-year span. Findings serve as a stark reminder of the poor prognosis associated with untreated AS irrespective of severity, suggesting patients...
“This research is the first of...
10/25/2023
Cath Lab Digest

Advertisement

Mohan EPLD Watchman LAAO
Clinical Trial Update: TAVR & LAAO
WATCH TAVR Trial Finds That Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners After TAVR
10/24/2023

Cleveland Clinic News

Cleveland Clinic News
The multicenter, randomized WATCH-TAVR trial set out to investigate the safety of implantation of the WATCHMAN 2.5 device at the time of TAVR and to compare the efficacy of WATCHMAN LAAO with contemporary medical therapy in this population of...
The multicenter, randomized WATCH-TAVR trial set out to investigate the safety of implantation of the WATCHMAN 2.5 device at the time of TAVR and to compare the efficacy of WATCHMAN LAAO with contemporary medical therapy in this population of...
The multicenter, randomized...
10/24/2023
Cath Lab Digest
Sapien 3 Valve (Edwards)
Clinical Trial Update: Sapien 3 THV
Five-Year Data From PARTNER 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve
10/24/2023

Edwards Lifesciences News

Edwards Lifesciences News
"The five-year follow-up findings from the PARTNER 3 trial reaffirm the clinical outcome benefits and bioprosthetic valve durability of SAPIEN 3 TAVR as a meaningful alternative to surgical therapy for low-risk severe, symptomatic AS...
"The five-year follow-up findings from the PARTNER 3 trial reaffirm the clinical outcome benefits and bioprosthetic valve durability of SAPIEN 3 TAVR as a meaningful alternative to surgical therapy for low-risk severe, symptomatic AS...
"The five-year follow-up...
10/24/2023
Cath Lab Digest
clinical trial update: aortic regurgitation
JenaValve Announces Late-Breaking Data From the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
10/24/2023

JenaValve Technologies, Inc. News

JenaValve Technologies, Inc. News ...
The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary efficacy endpoint. Outcomes were presented by Dr. Vinod Thourani (Piedmont Heart Institute, Atlanta, GA).
The trial met prespecified non-inferiority criteria for its primary safety endpoint and primary efficacy endpoint. Outcomes were presented by Dr. Vinod Thourani (Piedmont Heart Institute, Atlanta, GA).
The trial met prespecified...
10/24/2023
Cath Lab Digest

Advertisement

Medtronic Evolut PRO
Clinical Trial Update: Self-Expanding THV
Medtronic Evolut TAVR Platform Outperforms Surgery With Sustained Valve Performance for Low-Risk Patients at Four Years
10/24/2023

Medtronic News

Medtronic News
Since the approval of TAVR in low-risk surgical patients, there is an ongoing need for evidence to better understand the intermediate and longer-term durability of TAVR devices of different designs.
Since the approval of TAVR in low-risk surgical patients, there is an ongoing need for evidence to better understand the intermediate and longer-term durability of TAVR devices of different designs.
Since the approval of TAVR in...
10/24/2023
Cath Lab Digest
OpSens SavvyWire
Clinical Trial Update: SavvyWire
OpSens Announces Positive Clinical Results From SAFE-TAVI Study With SavvyWire in Europe
10/24/2023

OpSens News

OpSens News
"SAFE-TAVI Clinical Study: SavvyWire Efficacy and Safety in TAVI Procedures" will be presented on Wed, Oct 25, at 10:09am PST, at Moderated Abstracts Station 2 – Emerging Clinical Science & Research, Hall A, Exhibition Level, Moscone South
"SAFE-TAVI Clinical Study: SavvyWire Efficacy and Safety in TAVI Procedures" will be presented on Wed, Oct 25, at 10:09am PST, at Moderated Abstracts Station 2 – Emerging Clinical Science & Research, Hall A, Exhibition Level, Moscone South
"SAFE-TAVI Clinical Study:...
10/24/2023
Cath Lab Digest
News
Study Organized by Main Line Health Researchers Reverses FDA Warning on Vital Peripheral Artery Disease Treatment
10/24/2023
Dr. William Gray of Lankenau Institute for Medical Research, part of Main Line Health, guided research presented at cardiology conference and published by Lancet Wynnewood, PA — Four years ago, following a publication based on the limited...
Dr. William Gray of Lankenau Institute for Medical Research, part of Main Line Health, guided research presented at cardiology conference and published by Lancet Wynnewood, PA — Four years ago, following a publication based on the limited...
Dr. William Gray of Lankenau...
10/24/2023
Vascular Disease Management

Advertisement

TCT News
TCT: Primary Results of the ROTACUT Trial - New Combination of Techniques May Improve Stent Expansion for Patients Undergoing PCI
10/23/2023

Mount Sinai News

Mount Sinai News
The hypothesis of the study was that using a cutting balloon in addition to rotational atherectomy (RA) would improve coronary stent expansion.
The hypothesis of the study was that using a cutting balloon in addition to rotational atherectomy (RA) would improve coronary stent expansion.
The hypothesis of the study was...
10/23/2023
Cath Lab Digest

Advertisement

Advertisement

Subscriber

Cath Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use